Hoppa till innehål
banner-mesenkia-8

Kohei Miyazono new member at the royal Swedish academy of science.

Three new members elected to the Academy’s class for medical sciences

At its general meeting on 12 November, the Academy elected three new members. One of those is our scientific founder Kohei Miyazono. Read more about Kohei Miyazono here

 

Read the full article

More news

See all news

New Preclinical Findings Identify HVEM as a Promising Target in Aggressive Glioblastoma

Researchers have identified HVEM as a promising therapeutic target in mesenchymal glioblastoma...

Kohei Miyazono new member at the royal Swedish academy of science.

Kohei Miyazono has been elected as a new member to the Academy’s class for medical sciences at the royal ...

US Patent Application IP001 Receives Notice of Allowance

The US patent application IP001 has received an allowance for protection of our novel HVEM antagonistic single domain antibodies.

Cookiesamtycke

På webbplatsen används nödvändiga kakor för att webbplatsen ska fungera på ett bra sätt. Du kan även välja att samtycka till kakor för statistikinsamling.